Le Lézard
Classified in: Health
Subjects: PET, FVT

Spectrum Pharmacy Institute Offers New Veterinary Compounding Training Class


NEW BRUNSWICK, N.J., April 3, 2018 /PRNewswire/ -- Spectrum Pharmacy Institute (SPI), a state-of-the-art compounding education and training center, announces the new Compounding for the Veterinary Patient continuing education course for pharmacists, pharmacy technicians and marketers.

Veterinary compounding plays a crucial role in the health and treatment of animals. Compounding for the Veterinary Patient is a 13.75-hour (1.375 CEU) practice-based course that introduces pharmacists, technicians and marketers to veterinary pharmacy compounding.

The two-day accredited program provides the regulatory history of veterinary compounding along with pharmacology, compounding guidelines and options for the veterinary patient. The course is designed to help meet the challenges of customizing medications for a variety of species, along with the challenges of medication compliance. Instruction includes classroom and fully functional laboratory hands-on training.

Compounding for the Veterinary Patient is an interactive course presented at Spectrum Pharmacy Institute's compounding educational training facility in New Brunswick, NJ. Class instructor Brenda Poland, CPhT, is a compounding expert with more than thirty years' experience in veterinary compounding, retail, sterile and non-sterile human compounding.

Registration is now open for the new Compounding for the Veterinary Patient course. Classes are scheduled for three dates during 2018: May 17-18, August 9-10 and November 1-2. The course fee is $1,495. Early registration for the initial May 17-18 class qualifies for the 50 percent inaugural discount of $747.50, valid through April 4, 2018. To register, visit Spectrum Pharmacy Products.

All Spectrum Pharmacy Institute continuing education courses are reviewed by faculty of Rutgers University's Ernest Mario School of Pharmacy or the American College of Apothecaries. All the education programs are written and presented by subject matter experts.

Other classes offered at Spectrum Pharmacy Institute include:

May 9-11 ? Aug 1-3 ? Oct 24-26

Jul 18-20 ? Oct 10-12

June 14-15 ? Sep 8-9 ? Nov 29-30

June 1-3 ? Aug 17-19 ? Nov 9-11

June 28-29 ? Sep 20-21 ? Dec 13-14

About Spectrum Pharmacy Institute (SPI)

Spectrum Pharmacy Institute is a 42,000-square foot pharmacy distribution, manufacturing, and training facility located in New Brunswick, New Jersey. SPI is committed to providing the finest academic learning experience in the industry. The Institute offers the latest comprehensive lecture-based and hands-on compounding education. Learning programs feature a cutting-edge multi-media, audio-visual classroom and laboratory experience, including ISO-Class 7 & 8 cleanrooms, fully functional teaching laboratories, current compounding equipment and supplies, and USP 800 compliant facilities.

Courses are written and presented by subject matter experts, and all education programs are reviewed by faculty of Rutgers University's Ernest Mario School of Pharmacy or the American College of Apothecaries, and jointly accredited with Spectrum Pharmacy Institute. For more information, visit spectrumpharmacyinstitute.com.

 

SOURCE Spectrum Pharmacy Products


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: